NUS — NU Skin Enterprises Cashflow Statement
0.000.00%
- $408.12m
- $398.81m
- $1.49bn
- 97
- 96
- 33
- 89
Annual cashflow statement for NU Skin Enterprises, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 147 | 105 | 8.6 | -147 | 160 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 106 | 75.1 | 139 | 272 | -62.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -194 | -92.7 | -81.7 | -28.3 | -69.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 142 | 108 | 119 | 112 | 80.3 |
| Capital Expenditures | -68.6 | -59.1 | -58.5 | -41.6 | -34.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -20.1 | -8.02 | -76 | 3.62 | 205 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -88.7 | -67.1 | -135 | -38 | 171 |
| Financing Cash Flow Items | — | -5.08 | 0 | -6.3 | 3.62 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -105 | -99.5 | 10.7 | -133 | -202 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -63.1 | -74.9 | -8.67 | -69.2 | 51.7 |